Green Matters on MSN
ADHD Med Recall 2025: Another Batch of Generic Vyvanse Fails Tests
If you have been prescribed lisdexamfetamine dimesylate capsules to treat ADHD, you should know the FDA has recalled several lots of this medication.
Health and Me on MSN
FDA Recalled The Common ADHD Medication Vyvanse
The FDA issued a Class II recall for Sun Pharmaceutical's generic Vyvanse (lisdexamfetamine dimesylate capsules). The recall, ...
The Drug Enforcement Administration has increased the production limit for Takeda Pharmaceutical’s ADHD drug Vyvanse and its generic versions by about 24% to address the medicine’s ongoing shortage in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback